It’s time for us to make a difference again by joining forces with the American Diabetes Association to impact one of the nation’s most prevalent diseases.
Thank you for being part of UnitedHealth Group’s team at the 2019 Tour de Cure. Continue the tradition and join us in making a difference in diabetes care, research, and prevention by participating in this year’s Twin Cities Tour de Cure on Saturday, June 6. Last year, our collective team had more than 114 riders, runners and walkers and raised nearly $60,000. This year, help us meet our goal of 150 participants and $75,000.
The Tour de Cure is a great way to be part of something big - something that truly gives back to those who need it most. This year, we have an opportunity to contribute more to the mission of the American Diabetes Association with a $250 fundraising minimum for cyclists, $100 for walkers/runners and $50 for children 12 and under. Additionally, your $20 registration fee will help offset the production costs for the event, ensuring every dollar we raise supports those facing diabetes.
This year we have more team options and of course, friends and family are welcome to join us for this incredible event. Choose the right team for you, or even create your own team. Don’t wait, sign up today before registration fees increase on March 22!
Join our team or start your own UHG/UHC/Optum/Rally affiliated team at diabetes.org/tcuhg.
UnitedHealth Group (UHG, UHC, and Optum) employees can order a free jersey as part of the Corporate Apparel program. UnitedHealth Group is also matching UHG employee donations dollar-for-dollar, so your Tour de Cure time and dollars go further to benefit the American Diabetes Association.
After registering you will have access to your Participant Center, which is your fundraising hub. You will have a personal page to share your story, mobile apps, email templates and more. Celebrate, support, and advocate for those who are living with diabetes. Every mile covered and every dollar raised provides critical funds to help fight diabetes, bringing us closer to a cure. We hope to see you there.